Target Health Resources

Vasomax for the Treatment of Male Erectile Dysfunction

February 19, 2001

,
Clinical Research

|

Abstract

This paper reviews laboratory and clinical data concerning oral phentolamine mesylate, Vasomax, an alpha-1, alpha-2 adrenergic receptor antagonist developed specifically for treatment of erectile dysfunction.

Download Now
Boston University School of Medicine, Department of Urology
Irwin Goldstein, Culley Carson, Ray Rosen, and Anita Islam
February 19, 2001

Contact Target Health

Reach out today and let us know how we can help you!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form